PHARMACEUTICALS

Europe recalls generic heart drug made in China on cancer fears

Europe recalls generic heart drug made in China on cancer fears

Published 06/07/2018

LONDON (Reuters) - A number of high blood pressure and heart drugs containing an ingredient made in China are being recalled across Europe after an [more…]

EU makes it easier for companies to produce generic medicines for…

EU makes it easier for companies to produce generic medicines for…

Published 28/05/2018

BRUSSELS (Reuters) - The European Commission on Monday proposed to change intellectual property rules to let pharmaceutical companies produce generic drugs for export to countries [more…]

FDA chief questions protections on drug rebates, stocks fall

FDA chief questions protections on drug rebates, stocks fall

Published 04/05/2018

(Reuters) - U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health insurers should remain protected by [more…]

Too many cancer drugs? Crowded market gives investors pause

Too many cancer drugs? Crowded market gives investors pause

Published 02/05/2018

LONDON (Reuters) - In London’s world-famous Great Ormond Street children’s hospital, Dr. Karin Straathof is excited about a new cell-based medicine that offers hope for [more…]

Allergan migraine drug succeeds in second late-stage trial

Allergan migraine drug succeeds in second late-stage trial

Published 27/04/2018

NEW YORK (Reuters) - Allergan Plc on Friday announced positive results from a second Phase III trial for the 50 milligram dose of its drug [more…]

Big pharma, big data: why drugmakers want your health records

Big pharma, big data: why drugmakers want your health records

Published 01/03/2018

FILE PHOTO: A surgery nurse is seen beside the heart beat monitor in the operating theatre of the Unfallkrankenhaus Berlin (UKB) hospital in Berlin, Germany [more…]

Bayer pharmaceuticals head says there’s no pipeline problem

Bayer pharmaceuticals head says there’s no pipeline problem

Published 23/11/2017

LEVERKUSEN, Germany (Reuters) - Bayer is seeking to defend its pharmaceuticals business that will be diluted in importance by the takeover of Monsanto and faces [more…]

China to speed up drug approvals, will accept overseas trial data

China to speed up drug approvals, will accept overseas trial data

Published 09/10/2017

China is looking to speed up approvals for new drugs and plans to accept data from clinical trials carried out overseas, a potential boon for international drugmakers and patients who often face lengthy delays for new medicines to reach the market. [more…]

UK report plans boost for life sciences as Brexit looms

UK report plans boost for life sciences as Brexit looms

Published 30/08/2017

The British government has rekindled its industrial strategy, unveiled earlier this year to prepare the economy for Brexit, with plans to boost the country's pharmaceuticals sector via fresh investments and public-private collaborations. [more…]

Lupin sets off down Indian pharma`s long road to redemption

Lupin sets off down Indian pharma`s long road to redemption

Published 09/07/2017

An employee inspects tablets as they move along the production line at a pharmaceutical plant of Lupin, India's No. 2 drugmaker, in Verna, in the western state of Goa, India, June 9, 2017. Picture taken June 9, 2017. REUTERS/Danish Siddiqui

In 28 years in India's pharmaceuticals sector, Rajiv Desai has never been busier.

[more…]